Next-Generation Flu Vaccines Could Prevent Millions of Deaths, WHO Highlights
The World Health Organization and global health experts are calling for urgent investment in next-generation influenza vaccines that could save millions of lives by 2050, as new research shows the global health and economic benefits of more effective flu protection.
Current seasonal flu vaccines vary in effectiveness from year to year, but emerging technologies aim to create broader, longer-lasting protection against multiple strains of influenza. Experts say such vaccines could not only reduce hospitalizations and deaths but also substantially ease pressure on health systems during respiratory illness seasons.
In related medical research, a clot-busting drug called tenecteplase showed potential to help some stroke patients recover even when treatment started up to 24 hours after symptoms began, expanding life-saving options for stroke care.
Another study suggests underlying herpes infections may affect brain health in people with HIV, underscoring the need for integrated care approaches for neurological and infectious diseases.
As global health leaders push for innovation and stronger preventive measures, breakthroughs in flu vaccine research and stroke treatment offer hope, but also highlight the ongoing challenges in tackling infectious and chronic diseases worldwide.
